Ramzi Khalaf

474 total citations
6 papers, 42 citations indexed

About

Ramzi Khalaf is a scholar working on Oncology, Epidemiology and Immunology. According to data from OpenAlex, Ramzi Khalaf has authored 6 papers receiving a total of 42 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Epidemiology and 4 papers in Immunology. Recurrent topics in Ramzi Khalaf's work include Viral-associated cancers and disorders (4 papers), Cytomegalovirus and herpesvirus research (4 papers) and T-cell and Retrovirus Studies (2 papers). Ramzi Khalaf is often cited by papers focused on Viral-associated cancers and disorders (4 papers), Cytomegalovirus and herpesvirus research (4 papers) and T-cell and Retrovirus Studies (2 papers). Ramzi Khalaf collaborates with scholars based in United States. Ramzi Khalaf's co-authors include Farid Boulad, Richard J. O’Reilly, Susan E. Prockop, Nancy A. Kernan, Andromachi Scaradavou, Trudy N. Small, Neerav Shukla, Ekaterina Doubrovina, Esperanza B. Papadopoulos and Peter G. Steinherz and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Ramzi Khalaf

6 papers receiving 42 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ramzi Khalaf United States	4	21	19	15	11	10	6	42
Kate Hill United Kingdom	3	32 1.5×	28 1.5×	5 0.3×	14 1.3×	21 2.1×	6	54
Stéphane Gérart France	3	9 0.4×	14 0.7×	12 0.8×	72 6.5×	11 1.1×	3	83
Rachel Protheroe United Kingdom	3	11 0.5×	27 1.4×	15 1.0×	13 1.2×		10	53
Doyle Bosque United States	3	10 0.5×	22 1.2×	3 0.2×	11 1.0×	7 0.7×	8	34
Lifang Huang China	2	26 1.2×	3 0.2×	13 0.9×	5 0.5×	10 1.0×	4	35
Juliana Martínez Rolón Argentina	5	15 0.7×	29 1.5×	3 0.2×	11 1.0×	3 0.3×	12	45
Е. Г. Хамаганова Russia	4	7 0.3×	13 0.7×	8 0.5×	33 3.0×	5 0.5×	33	52
Katharina L. Gössling Germany	4	11 0.5×	6 0.3×	10 0.7×	9 0.8×	5 0.5×	5	41
Khushnuma Mullanfiroze India	3	31 1.5×	11 0.6×	5 0.3×	3 0.3×	11 1.1×	10	40
Mohamed Amine Bekadja Algeria	5	12 0.6×	33 1.7×	3 0.2×	6 0.5×	4 0.4×	19	64

Countries citing papers authored by Ramzi Khalaf

Since Specialization

Citations

This map shows the geographic impact of Ramzi Khalaf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramzi Khalaf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramzi Khalaf more than expected).

Fields of papers citing papers by Ramzi Khalaf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ramzi Khalaf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramzi Khalaf. The network helps show where Ramzi Khalaf may publish in the future.

Co-authorship network of co-authors of Ramzi Khalaf

This figure shows the co-authorship network connecting the top 25 collaborators of Ramzi Khalaf. A scholar is included among the top collaborators of Ramzi Khalaf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ramzi Khalaf. Ramzi Khalaf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Prockop, Susan E., Ekaterina Doubrovina, Farid Boulad, et al.. (2015). Banked EBV-specific T-cells from HLA-partially matched normal donors to induce durable remissions of rituximab refractory EBV⁺B-cell lymphomas post hematopoietic and organ allografts.. Journal of Clinical Oncology. 33(15_suppl). 10016–10016. 5 indexed citations

2.

Prockop, Susan E., Ekaterina Doubrovina, Farid Boulad, et al.. (2015). Abstract CT107: Epstein-Barr virus-specific cytotoxic T lymphocytes for treatment of rituximab-refractory Epstein-Barr virus-associated lymphoproliferative disorder. Cancer Research. 75(15_Supplement). CT107–CT107. 7 indexed citations

3.

Prockop, Susan E., Ekaterina Doubrovina, Juliet N. Barker, et al.. (2014). Third Party Donor Derived EBV Specific T Cells for the Treatment of Refractory EBV-Related Post-Transplant Lymphomas. Biology of Blood and Marrow Transplantation. 20(2). S49–S50. 2 indexed citations

4.

Prockop, Susan E., Aisha Hasan, Guenther Koehne, et al.. (2014). Third Party Donor Derived CMV Specific T Cells for the Treatment of Refractory CMV Viremia and Disease after Hematopoietic Stem Cell Transplant. Blood. 124(21). 184–184. 8 indexed citations

5.

Prockop, Susan E., Ekaterina Doubrovina, Juliet N. Barker, et al.. (2012). Third Party Donor Derived EBV Specific T Cells for the Treatment of Refractory EBV-Related Malignancies in Immunodeficient Recipients. Blood. 120(21). 577–577. 1 indexed citations

6.

Kobos, Rachel, Peter G. Steinherz, Nancy A. Kernan, et al.. (2011). Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Patients with Treatment-Related Myelodysplastic Syndrome or Acute Myelogenous Leukemia. Biology of Blood and Marrow Transplantation. 18(3). 473–480. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact